Disclaimer: The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment.
This blog is brought to you by Mellow Organic
If you are considering implementing CBD into your daily health routine then we would like to introduce you to Mellow Organic, we are the first and most trusted CBD products in Thailand. Our premium CBD products that we offer are Mellow CBD Oil made from pure CBD, Mellow Full Spectrum CBD Oil that contains a high amount of CBD along with THC and other cannabinoids from the cannabis plant and Mellow CBD Soothing Balm with pleasant vanilla scented balm with CBD infused ingredients. Our product is lab tested for Top Quality CBD content and zero toxicity.
A new study shows nearly 3% of healthy adolescents use commercial CBD products. Results provide insights into CBD use in minors while at the same time there is still much we don’t know about Cannabidiol.
Since cannabidiol (CBD), the non-intoxicating component of cannabis and was legalized in the United States by the 2018 Farm Bill, products containing the compound have flooded the consumer health sector. While there is a single FDA-approved medication containing CBD which can be used to treat rare forms of epilepsy, evidence for the efficacy of commercial CBD products, which generally contain low doses of CBD, is limited. However, this has not stopped their widespread and growing use.
A new study published in Cannabis and Cannabinoid Research reveals that nearly 3% of healthy adolescents aged 11-15 have used commercial CBD products for medicinal or health-related reasons. The study, led by Natasha Wade, Ph.D., assistant professor in the Department of Psychiatry at UC San Diego School of Medicine, is the first to investigate the prevalence and predictors of commercial CBD use in young, healthy adolescents.
The study suggests that the actual number of adolescents using commercial CBD products may be higher, as parents might not be comfortable reporting their use. Wade noted that the study's findings raise concerns about the chemical content of commercial CBD use in adolescents.
The study identified several predictors of commercial CBD use, including older age, having parents with some college education, and certain health conditions, such as sleep problems, mental health symptoms, and physical pain. Additionally, the researchers found that youth with more lenient parental attitudes towards cannabis use were more likely to use commercial CBD products.
The study also found that, for a sample of teens that had undergone hair toxicology testing, 23% of participants who used CBD products had THC in their hair, suggesting that some parents may be unknowingly giving their kids CBD products that contain THC.
The study highlights the need for regulation of CBD products to ensure that the products contain what the labels claim. Wade and her team are now working on a broader online survey to investigate why parents are giving CBD to their kids and whether it is effective in treating their conditions.
The study emphasizes the importance of clinicians asking about CBD use in their patients and parents being open about their use of CBD products. Wade noted that there is a need for more research to understand what CBD effectively treats in youth and at what doses, as well as the potential adverse effects associated with CBD use.
The study provides new insights into CBD use in minors and underscores the importance of further research to ensure the health and well-being of children. It highlights the need for regulation of CBD products and emphasizes the importance of clinicians asking about CBD use in their patients and parents being open about their use of CBD products.
コメント